Allison Aggon, DO
Surgery · Philadelphia, PANPI 1972759900
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,350 of the $2,216 with a category attached, or 60.9%. Elucent Medical accounts for 92.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $1,342 and has fallen 62.8% since, to $499 in 2025.
Across 15 payments — averaging $147.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elucent Medical$2K
- Myriad Genetic Laboratories, Inc.$60
- Davol Inc.$29
- Amgen$26
- GSK$20
- Tersera Therapeutics LLC$14
- plus $27 from 2 others
What the payments were for
- Consulting fees$1,35061%
- Speaking & faculty fees$1507%
- Food & beverage$71632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elucent Medical | 7 | $2,040 |
| Myriad Genetic Laboratories, Inc. | 2 | $60 |
| Davol Inc. | 1 | $29 |
| Amgen | 1 | $26 |
| GSK | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $14 |
| TELA Bio, Inc. | 1 | $14 |
| Clozex Medical Inc | 1 | $13 |
How this compares
$2,216 in reported general payments places this provider in the 60th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 11 | $18 |
| Ibuprofen | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Other surgery in Philadelphia
- Brett ChatmanPhiladelphia$178K
- David WernsingPhiladelphia$142K
- Said AzouryPhiladelphia$131K
- James MarkmannPhiladelphia$97K
- Daniel HewittPhiladelphia$89K
- Daniel HashimotoPhiladelphia$73K
- Scott KozinPhiladelphia$59K
- Prashanth PalvannanPhiladelphia$54K
- Henry HirschPhiladelphia$53K
- Erica PettkePhiladelphia$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.